---
title: "MDWD: Q2 revenue fell, but guidance held as EscharEx and NexoBrid programs advanced and U.S. sales grew"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295796876.md"
description: "Q2 2026 revenue declined year-over-year due to BARDA timing, but full-year guidance of $24–26 million was reaffirmed. EscharEx and NexoBrid programs advanced, with NexoBrid achieving record U.S. sales and a new Vericel agreement expected to boost H2 revenue.Original document: MediWound Ltd. [MDWD] SEC 6-K Current Report — Aug. 13 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T12:13:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295796876.md)
  - [en](https://longbridge.com/en/news/295796876.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295796876.md)
generator: "portal-rs"
---

# MDWD: Q2 revenue fell, but guidance held as EscharEx and NexoBrid programs advanced and U.S. sales grew

Q2 2026 revenue declined year-over-year due to BARDA timing, but full-year guidance of $24–26 million was reaffirmed. EscharEx and NexoBrid programs advanced, with NexoBrid achieving record U.S. sales and a new Vericel agreement expected to boost H2 revenue.

Original document: MediWound Ltd. \[MDWD\] SEC 6-K Current Report — Aug. 13 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MDWD.US](https://longbridge.com/en/quote/MDWD.US.md)
- [VCEL.US](https://longbridge.com/en/quote/VCEL.US.md)

## Related News & Research

- [MDWD: Validated enzymatic therapies drive strong growth, targeting $1B+ peak sales in chronic wounds](https://longbridge.com/en/news/295787113.md)
- [Vericel director Kevin F. McLaughlin disposes of 7,000 common shares worth $311,710](https://longbridge.com/en/news/295970279.md)
- [MediWound posts investor presentation on enzymatic burn and chronic-wound therapies NexoBrid, EscharEx](https://longbridge.com/en/news/295787062.md)
- [MediWound (NASDAQ:MDWD) Issues Earnings Results](https://longbridge.com/en/news/295866831.md)
- [Alibaba to sell gaming arm for US$1.5 billion in boost to AI pivot: Bloomberg](https://longbridge.com/en/news/296046350.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**